Article 30 Sep 2024 FDA Hosts Public Meeting On Post-Market Chemical Reassessment Strategy United States Healthcare
Article 27 Mar 2024 FDA Publishes Final Rule Revising Bases And Procedures For Revoking FCN Authorizations United States Healthcare